| # | Drug | Count |
|---|---|---|
| 0 | ALBUTEROL SULFATE | 76 |
| 1 | ACETAMINOPHEN | 57 |
| 2 | CETIRIZINE HYDROCHLORIDE | 34 |
| 3 | LOPERAMIDE HYDROCHLORIDE AND DIMETHICONE | 26 |
| 4 | EPINEPHRINE | 23 |
| 5 | ERGOCALCIFEROL | 22 |
| 6 | POLYETHYLENE GLYCOL 3350 | 22 |
| 7 | NIRMATRELVIR AND RITONAVIR | 21 |
| 8 | AVOBENZONE 2%, OCTISALATE 4.5%, OCTOCRYLENE 7% | 20 |
| 9 | LEVOTHYROXINE SODIUM | 20 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | AVOBENZONE, OCTISALATE, OCTOCRYLENE, AND OXYBENZONE | 2 | 0.2857 |
| 1 | (TO DELIVER) AVOBENZONE 2%, OCTISALATE 4.5%, OCTOCRYLENE 7% | 6 | 0.2222 |
| 2 | AVOBENZONE 2%, OCTISALATE 4.5%, OCTOCRYLENE 7% | 20 | 0.1802 |
| 3 | (TO DELIVER) AVOBENZONE 2%, HOMOSALATE 8%, OCTISALATE 4.5%, OCTOCRYLENE 7% | 14 | 0.1707 |
| 4 | AVOBENZONE 3%, HOMOSALATE 15%, OCTISALATE 5%, OCTOCRYLENE 10% | 15 | 0.1685 |
| 5 | AVOBENZONE 3%, HOMOSALATE 10%, OCTISALATE 5%, OCTOCRYLENE 5% | 15 | 0.1667 |
| 6 | FERRIC SUBSULFATE | 2 | 0.0769 |
| 7 | AVOBENZONE, HOMOSALATE, OCTISALATE, AND OCTOCRYLENE | 10 | 0.0388 |
| 8 | POTASSIUM CHLORIDE AND SODIUM CHLORIDE | 2 | 0.0333 |
| 9 | BENZOCAINE, BUTAMBEN, AND TETRACAINE HYDROCHLORIDE | 1 | 0.0303 |
| # | Drug class | Count |
|---|---|---|
| 0 | Nonsteroidal Anti-inflammatory Drug [EPC] | 40 |
| 1 | Osmotic Laxative [EPC] | 27 |
| 2 | Vitamin C [EPC] | 26 |
| 3 | Factor Xa Inhibitor [EPC] | 25 |
| 4 | Catecholamine [EPC] | 24 |
| 5 | alpha-Adrenergic Agonist [EPC] | 23 |
| 6 | beta-Adrenergic Agonist [EPC] | 23 |
| 7 | Corticosteroid [EPC] | 22 |
| 8 | Provitamin D2 Compound [EPC] | 22 |
| 9 | Dihydropyridine Calcium Channel Blocker [EPC] | 19 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Cholecystokinin Analog [EPC] | 1 | 0.0065 |
| 1 | Semifluorinated Alkane [EPC] | 5 | 0.0022 |
| 2 | Ectoparasiticide [EPC] | 5 | 0.0013 |
| 3 | Guanylate Cyclase-C Agonist [EPC] | 2 | 0.0010 |
| 4 | Provitamin D2 Compound [EPC] | 22 | 0.0007 |
| 5 | Plasma Volume Expander [EPC] | 2 | 0.0006 |
| 6 | alpha-Hydroxy Acid [EPC] | 1 | 0.0005 |
| 7 | Plasma Kallikrein Inhibitor [EPC] | 1 | 0.0004 |
| 8 | Lymphocyte Function-Associated Antigen-1 Antagonist [EPC] | 6 | 0.0004 |
| 9 | Bismuth [EPC] | 2 | 0.0004 |